Evaluation of demographic, pathologic, and clinical characteristics and overall survival of patients with colon cancer in Northern Iran (Mazandaran Province) during 2012-2019
Gastroenterology and Hepatology from Bed to Bench,
Vol. 13 No. 3 (2020),
2 June 2020
,
Page 209-218
https://doi.org/10.22037/ghfbb.v13i3.1775
Abstract
Aim: The present study aimed at evaluating the demographic, pathological and clinical characteristics of patients with colon cancer and also the survival rate and its related factors.
Background: Cancer is the most important barrier to increasing life expectancy in the world. Furthermore, colon cancer is the fourth leading cause of cancer in Iran.
Methods: In this descriptive-analytical study, 219 patients with colon cancer were investigated. Data were analyzed through descriptive and univariate methods using R software. Kaplan-Meier survival analysis and log-rank test were used to evaluate the survival rate of the patients.
Results: In the present study, 25% of patients were below 50 years of age. A family history of cancer was positive in 30% of the patients. According to the clinical symptoms of the patients, rectorrhagia was higher in patients with sigmoid tumor site, abdominal pain was higher in patients with transverse and ascending tumor sites, and anemia was higher in patients with ascending and caecum tumor sites (p< 0.05). The mean life expectancy of the patients was 53.71±2.07 months. Three-year, five-year and seven-year survival rates were 70, 49, and 37 %, respectively.
Conclusion: Half of the patients were diagnosed at advanced stage and the mean survival time at advanced stage was approximately four years. One-third of the patients had local recurrence. It is recommended that patients refer to specialists at specified time intervals for timely diagnosis of the disease and prevention of its recurrence. Providing effective training for people in order for them to acquire more knowledge, and performing screening tests will lead to early diagnosis and lower mortality.
Keywords: Colon cancer, Demographic, Clinical, Pathology, Survival analysis.
(Please cite as: Rahimi E, Yazdani Charati J, Mohammad pour Tahamtan RA, Maleki I. Evaluation of demographic, pathologic, and clinical characteristics and overall survival of the patients with colon cancer in Northern Iran (Mazandaran Province) during 2012-2019. Gastroenterol Hepatol Bed Bench 2020;13(3):209-218).
- colon cancer
- demographic
- clinical
- pathology
- survival analysis Introduction
How to Cite
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 2018;68:394-424.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Przegląd Gastroenterol 2019;14:89-103.
Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointestinal Oncol 2012;4:68-70.
Iran, Islamic Republic of Source: Globocan 2018. Available at: https://gco.iarc.fr/today/data/factsheets/populations/364-iran-islamic-republic-of-fact-sheets.pdf Accessed August 27, 2019.
Farhood B, Raei B, Ameri H, Shirvani M, Alizadeh A, Najafi M, et al. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Oncol 2019;23:7-15.
Shadmani FK, Ayubi E, Khazaei S, Sani M, Hanis SM, Khazaei S, et al. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiol Health 2017;39:e2017020.
Pakzad R, Moudi A, Pournamdar Z, Pakzad I, Mohammadian-Hashejani A, Momenimovahed Z, et al. Spatial Analysis of Colorectal Cancer in Iran. Asian Pacific J Cancer Prev 2016;17:53-8.
Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: molecular epidemiology and screening strategies. J Cancer Epidemiol 2015;643020.
Park SY, Lee HS, Choe G, Chung JH, Kim WH. Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location. Virchows Archiv 2006;449:40-7.
Arai T, Kasahara I, Sawabe M, Kanazawa N, Kuroiwa K, Honma N, et al. Microsatellite‐unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int 2007;57:205-12.
Papagrigoriadis S. Follow-up of patients with colorectal cancer: The evidence is in favour but we are still in need of a protocol. Int J Surg 2007;5:120-8.
Keshvari A, Fazeli MS, Kazemeini A, Meysamie A, Taromlou N, Kazem M. Evaluation of recurrent colorectal carcinoma after curative resection. Tehran Univ Med J TUMS Publications 2014;71:643-51.
Kraemer M, Wiratkapun S, Seow-Choen F, Ho Y, Eu K, Nyam D. Stratifying risk factors for follow-up. Dis Colon Rectum 2001;44:815-21.
Azadeh S, Moghimi-Dehkordi B, Fatem S, Pourhoseingholi M, Ghiasi S, Zali M. Colorectal cancer in Iran: an epidemiological study. Asian Pacific J Cancer Prev 2008;9:123-6.
Fakheri H, Janbabai G, Bari Z, Eshqi F. The epidemiologic and clinical-pathologic characteristics of colorectal cancers from 1999 to 2007 in Sari, Iran. J Mazandaran Univ Med Sci 2008;18:58-66.
Mirzaeipour A, Salehifar E, Janbabai G, Kouchaki B, Borhani S, Rashidi M. Demographic and clinical characteristics of patients with colorectal cancer. J Mazandaran Univ Med Sci 2015;24:66-73.
Hajmanoochehri F, Asefzadeh S, Kazemifar AM, Ebtehaj M. Clinicopathological features of colon adenocarcinoma in Qazvin, Iran: a 16 year study. Asian Pacific J Cancer Prev 2014;15:951-5.
Fatemi SR, Pourhoseingholi MA, Asadi F, Vahedi M, Pasha S, Alizadeh L, et al. Recurrence and five-year survival in colorectal cancer patients after surgery. Iranian J Cancer Prev 2015;8:13-8.
Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iranian Med 2009;12:161-9.
Ansa B, Coughlin S, Alema-Mensah E, Smith S. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014). J Clin Med 2018;7:22.
Lee IM. Physical activity and cancer prevention-data from epidemiologic studies. Med Sci Sports Exercise 2003;35:1823-7.
Karimi ZA, Saadat A, Jalalian HR, Esmaeili M. Epidemiology and survival analysis of colorectal cancer and its related factors. Kowsar Med J 2011;15:239-43.
Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-42.
Slattery ML, Friedman GD, Potter JD, Edwards S, Caan BJ, Samowitz W. A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Interdiscip Int J Am Cancer Society 1996;78:1666-70.
Salimzadeh H, Bishehsari F, Delavari A, Barzin G, Amani M, Majidi A, et al. Cancer risk awareness and screening uptake in individuals at higher risk for colon cancer: a cross-sectional study. BMJ Open 2016;6:e013833.
Golfam F, Golfam P, Neghabi Z. Frequency of all types of colorectal tumors in the patients referred to selected hospitals in tehran. Iranian Red Crescent Med J 2013;15:473-6.
Magaji BA, Moy FM, Roslani AC, Law CW. Descriptive epidemiology of colorectal cancer in University Malaya Medical Centre, 2001 to 2010. Asian Pacific J Cancer Prev 2014;15:6059-64.
Kumar S, Burney IA, Zahid KF, Souza PCD, Belushi M, Meki TDMWA FM, et al. Colorectal cancer patient characteristics, treatment and survival in Oman- a single center study. Asian Pacific J Cancer Prev 2015;16:4853-8.
Saidi H, Karuri D, Nyaim E. Correlation of clinical data, anatomical site and disease stage in colorectal cancer. East African Med J 2008;85:259-62.
Sale A, Saeed MF, Mazin E, Almahmeed EA, Ali AAH, Ali HAH, et al. Unlucky patient combining two rarities: sigmoid colon cancer mimicking appendicular abscess and pseudomembranous colitis involving the small bowel. Int Surg J 2018;5:1552-5.
Akhoond MR, Kazemnejad A, Hajizadeh E, Motlagh AG. Comparison of colon and rectum cancer: survival and prognostic factors. Gastroenterol Hepatol Bed Bench 2010;3:177-86.
Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi S. Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis. Asian Pacific J Cancer Prev 2009;10:815-21.
Gohari MR, Biglarian A, Bakhshi E, Pourhoseingholi MA. Use of an artificial neural network to determine prognostic factors in colorectal cancer patients. Asian Pacific J Cancer Prev 2011;12:1469-72.
Ghazali AK, Musa KI, Naing NN, Mahmood Z. Prognostic factors in patients with colorectal cancer at Hospital Universiti Sains Malaysia. Asian J Surg 2010;33:127-33.
Xiang Y, Jin F, Gao Y. Cancer survival in Shanghai, China, 1992-1995. IARC Sci Publications 2011;162: 55-68.
Kalcan S, Sisik A, Basak F, Hasbahceci M, Kilic A, Kosmaz K, et al. Evaluating factors affecting survival in colon and rectum cancer: A prospective cohort study with 161 patients. J Cancer Res Ther 2018;14:416-20.
Ulanja MB, Rishi M, Beutler BD, Sharma M, Patterson DR, Gullapalli N, et al. Colon Cancer Sidedness, Presentation, and Survival at Different Stages. J Oncol 2019;4315032.
Wang Y, Yang L, Zhou M, Shen L, Zhang J, Deng W, et al. Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014). Cancer Management Res 2018;10:1735-47.
Roshanaei G, Komijani A, Sadighi A, Faradmal J. Prediction of survival in patients with colorectal cancer referred to the Hamadan MRI center using of Weibull parameter model and determination of its risk factors during 2005-2013. J Arak Univ Med Sci 2014,16:41-9.
Chao-Hsien L, Cheng SC, Hong-Yi T, Chang SC, Ching CY, Shu-Fen W. The Risk Factors Affecting Survival in Colorectal Cancer in Taiwan. Iranian J Public Health 2018;47:519-30.
Nasiri S, Sorush A, Karamnezhad M, Mehrkhani F, Mosafa S, Hedayat A. Prognostic factors in the survival rate of colorectal cancer patients after surgery. Iranian J Surg 2010;18:50-6.
Hassan M, Suan M, Soelar SA, Mohammed NS, Ismail I, Ahmad F. Survival analysis and Prognostic factors for colorectal cancer patients in Malaysia. Asian Pacific J Cancer Prev 2016;17:3575-81.
Moghimi DB, Safaei A, Zali MR. Survival rates and prognostic factors in colorectal cancer patients. J Ilam Univ Med Sci 2008;16:33-43.
Li M, Li J, Zhao A, Gu J. Colorectal cancer or colon and rectal cancer? Oncology 2007;73:52-7.
- Abstract Viewed: 61 times
- PDF Downloaded: 33 times